InvestorsHub Logo

Bourbon_on_my_cornflakes

09/19/18 5:50 PM

#166102 RE: lt2211 #166101

PR that abstract title tomorrow Dr. M.

time for the rally to begin.

Proof of long term efficacy!

Longitudinal 148-Week Extension Study for ANAVEX®2-73 Phase 2a Alzheimer’s Disease Demonstrates Maintained Activities of Daily Living Score (ADCS-ADL) and Reduced Cognitive Decline (MMSE) for Patient Cohort on Higher Drug Concentration and Confirms Role of Patient Selection Biomarker

Proof of long-term efficacy + no big side effects = New STANDARD OF CARE